Interleukin (IL)-12 receptor beta 1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3 '-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma
顯示簡易詮釋資料 統計資料| 欄位 | 內容 | 語言 |
|---|---|---|
dc.citation.epage |
895 | en_US |
dc.citation.issue |
4 | en_US |
dc.citation.spage |
886 | en_US |
dc.citation.volume |
87 | en_US |
dc.citation.woscount |
13 | |
dc.contributor.author |
Hsieh, Yao-Yuan | en_US |
dc.contributor.author |
Chang, Chi-Chen | en_US |
dc.contributor.author |
Tsai, Chang-Hai | en_US |
dc.contributor.author |
Lin, Cheng-Chieh | en_US |
dc.contributor.author |
Tsai, Fuu-Jen | en_US |
dc.contributor.department |
生物科技學系 | zh_TW |
dc.contributor.department |
Department of Biological Science and Technology | en_US |
dc.date.accessioned |
2014-12-08T15:14:19Z | |
dc.date.available |
2014-12-08T15:14:19Z | |
dc.date.issued |
2007-04-01 | en_US |
dc.description.abstract |
Objective: To investigate whether certain polymorphisms are correlated with leiomyoma susceptibility, i.e., interleukin (IL)-1, IL-2, IL-4, IL-8, IL-12, and IL-18, which are all immunomodulatory cytokines that play important roles in host immune responses against cancers. Setting: Departments of gynecology and genetics in a medical center. Patient(s): Women were divided into: [1] a leiomyoma group (n = 162) and [2] a nonleiomyoma group (n = 156). Intervention(s): Genotyping for the IL-1 beta-511 promoter, IL-1 beta exon 5, IL-1Ra, IL-2 114, IL-4 -590 intron 3, IL-8 3'-UTR 2767, IL-12R beta 1 codon 378, and IL-18 105 were evaluated by polymerase chain reaction-restriction fragment length polymorphism. Main Outcome Measurement(s): Genotypes and allelic frequencies in both groups were compared. Result(s): Proportions of IL-12R beta 1 codon 378 *CC/CG/GG in the leiomyoma and nonleiomyoma groups were: [1] 7.4%/43.8%/48.8% and [2] 11.5%/54.5%/34%, respectively. Distributions of other polymorphisms in both groups were not significantly different. Proportions of IL-1 beta-511 promoter *CC/CT/TT were: [1] 22.8%/50%/ 27.2% and [2] 21.8%/57.1%/21.1% in the leiomyoma and nonleiomyoma groups, respectively. The IL-1 beta exon 5 *E1 homozygote/heterozygote/E2 homozygote were: [1] 96.3%/3.7%/0% and [2] 96.9%/3.1%/0% in the leiomyoma and nonleiomyoma groups, respectively. Alleles I/II/III/IV/V for IL-1Ra were: [1] 92.6%/7.1%/0.3%/ 0/0% and [2] 93.9%/5.7%/0%/0.4/0% in the leiomyoma and nonleiomyoma groups, respectively. The IL-2 114 G homozygote/heterozygote/T homozygote were: [1] 27.8%/49.4%/22.8% and [2] 20.5%/53.2%/26.3% in the leiomyoma and nonleiomyoma groups, respectively. The IL-4 -590 intron 3 *RP1 homozygote/heterozygote/ RP2 homozygote were: [1] 64.8%/32.7%/2.5% and [2] 69.2%/26.9%/3.9% in the leiomyoma and nonleiomyoma groups, respectively. The IL-8 3'-UTR 2767 A homozygote/heterozygote/G homozygote were: [1] 14.2%/ 43.8%/42% and [2] 20.5%/41.7%/37.8% in the leiomyoma and nonleiomyoma groups, respectively. The IL-18 *AA/AC/CC were: [1] 56.8%/40.7%/2.5% and [2] 59%/39.7%/1.3% in the leiomyoma and nonleiomyoma groups, respectively. Conclusion(s): The IL-12R beta 1 codon 378 *G homozygote and G allele are related to a higher susceptibility to leiomyoma. The IL-1 beta-511 promoter, IL-1 beta exon 5, and IL-1Ra, IL-2 114, IL-4 -590 intron 3, IL-8 3'-UTR 2767, and IL-18 105 gene polymorphisms are not correlated with the development of leiomyoma. | en_US |
dc.identifier.doi |
10.1016/j.fertnstert.2006.07.1541 | en_US |
dc.identifier.issn |
0015-0282 | en_US |
dc.identifier.journal |
FERTILITY AND STERILITY | en_US |
dc.identifier.uri |
http://dx.doi.org/10.1016/j.fertnstert.2006.07.1541 | en_US |
dc.identifier.uri |
https://ir.lib.nycu.edu.tw/handle/11536/10938 | |
dc.identifier.wosnumber |
WOS:000245788600023 | |
dc.language.iso |
en_US | en_US |
dc.subject |
cytokine | en_US |
dc.subject |
IL-1 | en_US |
dc.subject |
IL-2 | en_US |
dc.subject |
IL-4 | en_US |
dc.subject |
IL-8 | en_US |
dc.subject |
IL12 | en_US |
dc.subject |
IL-18 | en_US |
dc.subject |
leiomyoma | en_US |
dc.subject |
polymorphism | en_US |
dc.title |
Interleukin (IL)-12 receptor beta 1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3 '-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma | en_US |
dc.type |
Article | en_US |
檔案
本條目沒有附加檔案。
所屬典藏: 期刊論文
引用此條目
Hsieh, Y.-Y., Chang, C.-C., Tsai, C.-H., Lin, C.-C., & Tsai, F.-J. (2007). Interleukin (IL)-12 receptor beta 1 codon 378 G homozygote and allele, but not IL-1 (beta-511 promoter, 3953 exon 5, receptor antagonist), IL-2 114, IL-4-590 intron 3, IL-8 3 '-UTR 2767, and IL-18 105, are associated with higher susceptibility to leiomyoma. FERTILITY AND STERILITY, 87(4), 886–895. https://doi.org/10.1016/j.fertnstert.2006.07.1541
引用文字依 APA 第 7 版格式自動產生,使用前請再核對。
分享
永久網址:https://ir.lib.nycu.edu.tw/handle/11536/10938